Hallucinations in AI: How GSK is addressing a critical problem in drug development - Peer2Peer

Venture Beat Acc

Hallucinations in AI: How GSK is addressing a critical problem in drug development

Jan 14, 2025

Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems.Read More

https://venturebeat.com/ai/hallucinations-in-ai-how-gsk-is-addressing-a-critical-problem-in-drug-development/

Respond, make new discussions, see other discussions and customize your news...
Log in.

To add this website to your home screen:

1. Tap

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Terms of Service